99983-92-3 Usage
Uses
Used in Pharmaceutical Research:
2-(benzylsulfanyl)-6-chloropyrimidin-4-amine is used as a building block for the development of new drugs, leveraging its unique structural features and properties. Its potential applications in drug discovery make it a valuable compound for researchers in the field of medicinal chemistry.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(benzylsulfanyl)-6-chloropyrimidin-4-amine is used as a key intermediate compound. Its presence in the synthesis process allows for the creation of a variety of complex molecules, which can be further utilized in various chemical and pharmaceutical applications.
Used in Medicinal Chemistry:
2-(benzylsulfanyl)-6-chloropyrimidin-4-amine is employed as a starting material in the design and synthesis of novel therapeutic agents. Its structural versatility and potential for modification make it an attractive candidate for the development of innovative drugs with improved efficacy and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 99983-92-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,9,8 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 99983-92:
(7*9)+(6*9)+(5*9)+(4*8)+(3*3)+(2*9)+(1*2)=223
223 % 10 = 3
So 99983-92-3 is a valid CAS Registry Number.
99983-92-3Relevant academic research and scientific papers
Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists
Austin, Rupert P.,Bennion, Colin,Bonnert, Roger V.,Cheema, Lal,Cook, Anthony R.,Cox, Rhona J.,Ebden, Mark R.,Gaw, Alasdair,Grime, Ken,Meghani, Premji,Nicholls, David,Phillips, Caroline,Smith, Neal,Steele, John,Stonehouse, Jeffrey P.
, p. 1616 - 1620 (2015/03/30)
Antagonism of the chemokine receptor CXCR2 has been proposed as a strategy for the treatment of inflammatory diseases such as arthritis, chronic obstructive pulmonary disease and asthma. Earlier series of bicyclic CXCR2 antagonists discovered at AstraZene
Pyrimidine-thioalkyl and alkylether compounds
-
Page 11, (2010/11/29)
The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula I and pyrimidine-thioalkyl and alkylethers of Formula IA, namely the compounds of Formula I whereR4 is selected from the group consisting of -H or -NRsub
